Answers to the questions your compliance, clinical, and finance teams actually ask.

A patented point-of-care reader designed for rapid infection screening in skilled nursing and other regulated facilities. It reads rapid lateral flow tests (COVID, flu, RSV, strep, or drug tests) in under a minute and produces tamper-evident, auditable records automatically.

Today, SNFs rely on rapid infection tests that can be reused, contaminated, or swapped — leaving facilities exposed to HAI liability and regulatory risk. VynMed detects strip tampering in real time and produces the forensic record CMS surveyors and attorneys demand — so when they ask "how do you know?", there's a real answer.

Primarily skilled nursing facilities (SNFs) managing infection screening for COVID, flu, RSV, strep, and other respiratory infections. The same platform also supports drug testing verification. Any facility that needs point-of-care verification with auditable records.

We're in the design-partner phase. We're actively onboarding a small number of pilot facilities so we can tune the workflow to real resident care — not a lab benchtop.

Each pilot is scoped as a short, outcome-focused engagement with a named clinical and administrative sponsor at the facility. You get the device, training, and direct access to our team. We get honest feedback about what actually works on your floor.

Pricing is structured around the endpoint device plus a recurring software and support tier. We'll share tier details under NDA during your first call — along with an ROI model specific to your facility count and test volume.

VynMed is built around HIPAA's administrative, physical, and technical safeguards. We sign BAAs with every covered entity we work with. See our Security page for the full breakdown.

Test results and audit logs reside with you (the client) inside an isolated tenant. We do not sell, share, or use resident data for advertising, model training, or secondary research.

We are working with regulatory counsel on the appropriate pathway for each claim the product makes. We'll share our current regulatory strategy and timeline during due diligence — nothing is fabricated on this page.

VynMed Inc. is a Delaware C-Corp founded by Walter Bischoff Jr, the inventor named on US Patent 12,308,098 B1. The company is incorporated, has an EIN, an operating bank account, and an issued US utility patent.

Yes, on a defined round with a clear use of funds tied to getting the first pilot facilities live. If you're an aligned investor, email [email protected] and we'll get you into the data room.

Email [email protected] or call (702) 900-8503. Real people, small team, fast replies.